← Eichor
Condition: Ftd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ftd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration
NA · 1 location(s) · Università degli Studi di Brescia · NCT07316413
GENetic Fronto Temporal Dementia Initiative in Lille
NA · 1 location(s) · University Hospital, Lille · NCT04639622
Stimulating the Aging Brain Using Brain and Sensory Stimulation
NA · 1 location(s) · Medical College of Wisconsin · NCT07650188
Genetic Frontotemporal Dementia Initiative for Neurodevelopment
Phase N/A · 1 location(s) · Western University · NCT05779813
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
Phase 2 · 3 location(s) · Johns Hopkins University · NCT05386394
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
Phase N/A · 1 location(s) · University of Miami · NCT00317616
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
Phase 1 · 5 location(s) · Institute for Molecular Medicine · NCT07158905
Social-cognitive Functioning: Validation of a New Neuropsychological Test
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05558709
Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment
NA · 2 location(s) · University Hospital, Geneva · NCT06618872
Speech and Language Interventions for Italian People With PPA
Phase N/A · 2 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT06739967
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT00344331
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
Phase 1/Phase 2 · 1 location(s) · David Wilson · NCT05374278
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treat
Phase 2 · 14 location(s) · Delcath Systems Inc. · NCT06607458
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Phase 2 · 2 location(s) · Case Comprehensive Cancer Center · NCT07146646
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT03225144
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Phase 1 · 1 location(s) · Joanne Kurtzberg, MD · NCT02254863
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Phase 1 · 10 location(s) · Eli Lilly and Company · NCT06297590
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Fro
Phase 1/Phase 2 · 19 location(s) · AviadoBio Ltd · NCT06064890
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Var
NA · 1 location(s) · Johns Hopkins University · NCT03887481
Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease
NA · 2 location(s) · Hôpital le Vinatier · NCT04946916
Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia
NA · 1 location(s) · University Hospital, Toulouse · NCT04957537
Proteinopathies Expression in Skin of Neurodegenerative Disorders
Phase N/A · 1 location(s) · Universidad Autonoma de San Luis Potosí · NCT06528964
Clinical Procedures to Support Research in ALS
Phase N/A · 11 location(s) · University of Miami · NCT03489278
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Phase N/A · 27 location(s) · Mayo Clinic · NCT04363684
A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
Phase 3 · 6 location(s) · Jiangsu Simcere Pharmaceutical Co., Ltd. · NCT07361003
Amyotrophic Lateral Sclerosis (ALS) Families Project
Phase N/A · 1 location(s) · Columbia University · NCT03865420
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
NA · 1 location(s) · Kuopio University Hospital · NCT05326750
Enhancing Language Function in Aphasia
NA · 1 location(s) · University of Arizona · NCT05443633
Long Term Effect of Brain Stimulation in PPA
NA · 1 location(s) · Hospital San Carlos, Madrid · NCT07158216
Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders
Phase N/A · 1 location(s) · Nantes University Hospital · NCT06059313
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.